← Back
Data updated: Mar 10, 2026
KNACK
Infectious DiseaseDermatology
KNACK is a generic drug manufacturer focused on Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.
2022
Since
5
Drugs
-
Trials
175
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROCURONIUM BROMIDE 2026-01-06
LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
ROCURONIUM BROMIDE 2025-10-24
PANTOPRAZOLE SODIUM 2025-10-15
Labeling
PANTOPRAZOLE SODIUM 2025-10-15
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-10-02
PANTOPRAZOLE SODIUM 2025-10-01
Labeling
PANTOPRAZOLE SODIUM 2025-10-01
Labeling
PANTOPRAZOLE SODIUM 2025-10-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 2022-02-15
- Latest
- 2026-01-06
- Applications
- 5